| Medical Mutual | Elahere® (mirvetuximab soravtansine-gynx) (Intravenous) (EOV) | 2025-09-01 |
| Medical Mutual | Fyarro® (sirolimus albumin-bound) (Intravenous) (EOV) | 2025-09-01 |
| Medical Mutual | Ixempra® (ixabepilone) (Intravenous) (EOV) | 2025-09-01 |
| Medical Mutual | Yondelis® (trabectedin) (Intravenous) (EOV) | 2025-09-01 |
| Medical Mutual | Zaltrap® (ziv-aflibercept) (Intravenous) (EOV) | 2025-09-01 |
| Medical Mutual | Ziihera® (zanidatamab-hrii) (Intravenous) (EOV) | 2025-09-01 |
| Paramount Healthcare | Outpatient Rehabilitation Therapy Services,
Physical Therapy (PT)
Occupational Therapy (OT)
Speech Therapy (ST) | 2025-09-01 |
| Paramount Healthcare | Light Therapies for Dermatological Conditions-
Phototherapy, Photochemotherapy, and
Laser Therapy | 2025-09-01 |
| Paramount Healthcare | Gastric Electrical Stimulation (GES) | 2025-09-01 |
| Paramount Healthcare | Vision Therapy | 2025-09-01 |